Unknown

Dataset Information

A novel defined risk signature based on pyroptosis-related genes can predict the prognosis of prostate cancer.


ABSTRACT:

Background

Pyroptosis can not only inhibit the occurrence and development of tumors but also develop a microenvironment conducive to cancer growth. However, pyroptosis research in prostate cancer (PCa) has rarely been reported.

Methods

The expression profile and corresponding clinical data were obtained from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. Patients were divided into different clusters using consensus clustering analysis, and differential genes were obtained. We developed and validated a prognostic biomarker for biochemical recurrence (BCR) of PCa using univariate Cox analysis, Lasso-Cox analysis, Kaplan-Meier (K-M) survival analysis, and time-dependent receiver operating characteristics (ROC) curves.

Results

The expression l

SUBMITTER: Hu D 

PROVIDER: S-EPMC8822680 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature